CanBas Co., Ltd. (TSE: 4575)
Health Care · Biotechnology · JP
¥801.00
+8.39% today · -21.4% 1Y
CanBas Co., Ltd. (TSE: 4575) operates in the Biotechnology industry within the Health Care sector. The company is valued at $96.69M and employs 18 people.
Over the last twelve months the share price has lost 21.4%, trading between 506.00 and 1.11K.
Tweenvest scores CanBas Co., Ltd. across four factors: quality 45/100, value 48/100. Its strongest factor is value.
4575 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $96.69M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -66.39
- Dividend yield
- —
- Beta (5Y)
- -0.83
- 52-week high
- ¥1,106.00
- 52-week low
- ¥506.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.11M
- Employees
- 18
- Next earnings
- —
About CanBas Co., Ltd.
CanBas Co., Ltd. is a biopharmaceutical company in the clinical stage, dedicated to discovering and developing new therapies for cancer patients. Its main investigational compounds include CBP501, a calmodulin-modulating peptide aimed at treating various cancers, and CBS9106, a reversible exportin-1 inhibitor currently in Phase I clinical trials for solid tumors. The company also engages in a strategic partnership with Stemline Therapeutics, Inc. Established in Numazu, Japan, in 2000, CanBas Co., Ltd. continues its work in oncology.
- ISIN
- JP3244570002
- Founded
- 2000
- Listed since
- Sep 17, 2009
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biomea Fusion, Inc.NasdaqGS: BMEA | $98.58M | $0.98 | -27.93% |
| Genexine, Inc.KOSDAQ: A095700 | $98.27M | ₩2,905.00 | +4.87% |
| Novogenia AGMUN: 7V0 | $98.11M | €7.20 | — |
| OnKure Therapeutics, Inc.NasdaqGM: OKUR | $97.60M | $2.35 | -2.70% |
| Energenesis Biomedical CO.,LTD.TWSE: 6657 | $95.81M | NT$34.85 | +5.93% |
| Senhwa Biosciences, Inc.TPEX: 6492 | $94.77M | NT$33.90 | -1.45% |
| SynAct Pharma ABOM: SYNACT | $94.64M | Skr17.20 | +1.78% |
| Atara Biotherapeutics, Inc.NasdaqGS: ATRA | $94.15M | $9.36 | -0.27% |
Figures last refreshed Oct 11, 2026.